![5α-Reductase inhibitors alter steroid metabolism and may contribute to insulin resistance, diabetes, metabolic syndrome and vascular disease: a medical hypothesis 5α-Reductase inhibitors alter steroid metabolism and may contribute to insulin resistance, diabetes, metabolic syndrome and vascular disease: a medical hypothesis](https://www.degruyter.com/document/doi/10.1515/hmbci-2014-0025/asset/graphic/hmbci-2014-0025_fig1.jpg)
5α-Reductase inhibitors alter steroid metabolism and may contribute to insulin resistance, diabetes, metabolic syndrome and vascular disease: a medical hypothesis
![Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study | The BMJ Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study | The BMJ](https://www.bmj.com/content/bmj/365/bmj.l1204/F2.medium.jpg)
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study | The BMJ
![Solubility of dutasteride in different surfactants and co-surfactants... | Download Scientific Diagram Solubility of dutasteride in different surfactants and co-surfactants... | Download Scientific Diagram](https://www.researchgate.net/publication/270965172/figure/fig2/AS:350313484701698@1460532651380/Solubility-of-dutasteride-in-different-surfactants-and-co-surfactants-at-25-C-mean.png)
Solubility of dutasteride in different surfactants and co-surfactants... | Download Scientific Diagram
![Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction](https://www.degruyter.com/document/doi/10.1515/hmbci-2017-0015/asset/graphic/j_hmbci-2017-0015_fig_004.jpg)
Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
![Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction](https://www.degruyter.com/document/doi/10.1515/hmbci-2017-0015/asset/graphic/j_hmbci-2017-0015_fig_003.jpg)
Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
Pradhan Mantri Bhartiya Janaushadhi Pariyojana - PMBJP's high-quality generic medicines for Diabetes are affordable & available across 7000+ Jan Aushadhi Kendra. Visit your nearest Kendra, today. To know more, download the Jan
![Cureus | Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical) Cureus | Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)](https://assets.cureus.com/uploads/figure/file/180090/lightbox_8696e140638411ebae43cb7cb63ca9e6-1.png)
Cureus | Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It's Time to Sound the Alarm
![Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study | The BMJ Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study | The BMJ](https://www.bmj.com/content/bmj/365/bmj.l1204/F4.medium.jpg)
Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study | The BMJ
![Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction](https://www.degruyter.com/document/doi/10.1515/hmbci-2017-0015/asset/graphic/j_hmbci-2017-0015_fig_006.jpg)